SCHULD Veränderung Datum
Abbott USD 34.05B 20.19B 2026-03
Align Technology USD 120.84M 4.8M 2026-06
AtriCure USD 71.05M 736K 2026-06
Baxter International USD 9.67B 20M 2026-06
Becton, Dickinson and Co. USD 16.81B 471M 2026-06
Boston Scientific USD 12.62B 1.6B 2026-06
Cardinal Health USD 8.82B 71M 2026-09
Cooper Companies USD 2.46B 39.5M 2026-03
Dexcom USD 1.24B 154.7M 2026-09
Edwards Lifesciences USD 598.8M 105.6M 2026-09
Eli Lilly USD 54.91B 11.54B 2026-06
Globus Medical USD 111.19M 4.03M 2026-06
ICU Medical USD 1.15B 79.35M 2026-09
Inogen USD 0 0 2022-06
Insulet USD 962.1M 13.7M 2026-09
Integra LifeSciences USD 2.05B 9.43M 2026-06
J&J USD 49.04B 5.95B 2026-06
Medtronic USD 28.15B 192M 2026-06
Merit Medical Systems USD 820.12M 1.44M 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Solventum Corp USD 7.91B 97M 2025-03
Stryker USD 14.18B 16M 2026-09
Tandem Diabetes Care USD 603.39M 811K 2026-09
Teleflex USD 2.87B 186.84M 2026-06
West Pharmaceutical Services USD 202.9M 109.2M 2026-09
Zimmer Biomet Holdings USD 7.5B 25.2M 2026-09